Indications and uses
DERMESSE BALANCER is indicated for the gradual bleaching of hyperpigmented skin conditions such as chlosma, melasma, freckles, senile lentigines and other unwanted areas of melanin hyperpigmentation.
DERMESSE BALANCER is indicated for the gradual bleaching of hyperpigmented skin conditions such as chlosma, melasma, freckles, senile lentigines and other unwanted areas of melanin hyperpigmentation.
RX Only
FOR EXTERNAL USE ONLY
DERMESSE BALANCER contains: Hydroquinone 40mg/gm. See label on bottle for complete list of ingredients. Following is its chemical structure:
Topical application of hydroquinone produces a reversible depigmentation of the skin by inhibition of the enzymatic hydroquinone. oxidation of tyrosine to 3, 4-dihydroxyphenylalanine (dopa) and suppression of other melanocyte metabolic processes.
The selective inhibition of the enzyme affects melanogenesis in the melanocytes resulting in cessation of melanin formation and subsequent reduction in pigmentation. Additional studies indicate Hydroquinone acts on the essential subcellular metabolic processes of melanocytes with resultant cytolysis, i.e. nonenzymediated depigmentation.
Exposure to sunlight or ultraviolet light will cause regimentation of the bleached areas, which may be prevented by the use of sunblocking agents.
DERMESSE BALANCER is indicated for the gradual bleaching of hyperpigmented skin conditions such as chlosma, melasma, freckles, senile lentigines and other unwanted areas of melanin hyperpigmentation.
Prior history of sensitivity or allergic reaction to this product or any of its ingredients. The safety of topical Hydroquinone use during pregnancy or in children (12 years and under) has not been established.
See Warnings
Animal reproduction studies have not been conducted with topical Hydroquinone. It is also not known whether Hydroquinone can cause fetal harm when used topically on a pregnant woman or can affect reproductive capacity. It is not known to what degree, if any, topical Hydroquinone is absorbed systemically. Topical Hydroquinone should be used in women only when clearly indicated.
It is not known whether topical Hydroquinone is absorbed or excreted in human milk. Caution is advised when topical Hydroquinone is used by a nursing mother.
Safety and effectiveness in children below the age of 12 years have not been established.
No systemic reactions have been reported. Occasional cutaneous hypersensitivity (localized contact dermatitis) may occur in which case the medication should be discontinued and the physician notified immediately
There have been no systemic reactions reported from the use of topical Hydroquinone. However, treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation which does not preclude treatment.
A thin application of DERMESSE BALANCER should be applied to the affected area twice daily or as directed by a physician. Consult product label for instructions on whether to rub in or not. There is no recommendation for children under the age of 12 years of age except under the advice and supervision of a physician.
DERMESSE BALANCER is available as follows:
2 Oz. (57g) bottle
DERMESSE BALANCER should be stored at controlled room temperature (15°-30°C) (59°-86°F). Darkening of this product is normal. This will not affect performance or safety.
Distributed By
Axia Medical Solutions Carlsbad, California 92011
| Class | Version | Type | Effective |
|---|---|---|---|
| HYDROQUINONE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c5cd4727-ac49-4409-82b1-5bd8006c3ec7 | Product name | 1 | 20171122 |
| 85490a6b-2306-6bf2-c51b-eb63537dc2da | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68723-143-02 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-5cac-a910-e053-dadaa90a0b85 | Dermesse Balancer |
| 68723-143-02 | 2021-02-19 | C162847 | 48780-1 | ba0f9c33-5cac-a910-e053-dadaa90a0b85 | Dermesse Balancer |
| 68723-143-02 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-5cac-a910-e053-dadaa90a0b85 | Dermesse Balancer |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68723-143-02 | Balancer | 1 in 1 BOX | CREAM | 1 | 3 | |
| 68723-143-02 | Balancer | 57 g in 1 BOTTLE | CREAM | 57 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68723-143 | 68723-143-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Hydroquinone | XV74C1N1AE | ACTIB |
| ASCORBIC ACID | PQ6CK8PD0R | IACT |
| BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | IACT |
| CETYL ALCOHOL | 936JST6JCN | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| GLYCOLIC ACID | 0WT12SX38S | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| WATER | 059QF0KO0R | IACT |
| CAULOSIDE D | 4N5Z068GAZ | IACT |
| SODIUM LAURYL SULFATE | 368GB5141J | IACT |
| SODIUM METABISULFITE | 4VON5FNS3C | IACT |
| STEARYL ALCOHOL | 2KR89I4H1Y | IACT |
| .ALPHA.-TOCOPHEROL SUCCINATE, D- | LU4B53JYVE | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d950ca1b-964b-4534-a6fc-7a29e5e4fd7f | 7271877f-2ed5-4e58-84a1-dce3844a0bc5 | 2021-02-19 | Warnings, Adverse reactions | d950ca1b-964b-4534-a6fc-7a29e5e4fd7f 7271877f-2ed5-4e58-84a1-dce3844a0bc5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.